ID: ALA5201051

Max Phase: Preclinical

Molecular Formula: C20H37NO4

Molecular Weight: 355.52

Associated Items:

Representations

Canonical SMILES:  CC12CC3CC(C)(C1)CC(NCCOCCOCCOCCO)(C3)C2

Standard InChI:  InChI=1S/C20H37NO4/c1-18-11-17-12-19(2,14-18)16-20(13-17,15-18)21-3-5-23-7-9-25-10-8-24-6-4-22/h17,21-22H,3-16H2,1-2H3

Standard InChI Key:  XZXTWSSKVOIBRH-UHFFFAOYSA-N

Associated Targets(non-human)

HT-22 3261 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 355.52Molecular Weight (Monoisotopic): 355.2723AlogP: 2.37#Rotatable Bonds: 12
Polar Surface Area: 59.95Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.36CX LogP: 1.67CX LogD: -1.11
Aromatic Rings: 0Heavy Atoms: 25QED Weighted: 0.53Np Likeness Score: -0.14

References

1. Lu K, Wang Y, Zhang H, Tian C, Wang W, Yang T, Qi B, Wu S..  (2022)  Rational Design of a Theranostic Agent Triggered by Endogenous Nitric Oxide in a Cellular Model of Alzheimer's Disease.,  65  (13.0): [PMID:35729801] [10.1021/acs.jmedchem.2c00399]

Source